Clinical care and research studies for kidney cancer at UCLA is facilitated through the UCLA Kidney Cancer Program. Established in 1989, it is one of the first comprehensive kidney cancer programs in the United States and has a storied history of accomplishments. The UCLA Kidney Cancer Program provides state-of-the-art care to patients with kidney cancer, in a convenient and coordinated multidisciplinary setting within the Institute of Urologic Oncology consisting of members of:
The team of physicians, surgeons and clinical professionals are world-renowned experts in the diagnosis, management and treatment of kidney cancer, from localized tumors confined to the kidney to the most complicated metastatic kidney tumors that have spread to other parts of the body. The UCLA Kidney Cancer Program aims to provide patients the best available treatment as well as by responding to their individual needs and concerns.
By offering a large portfolio of clinical trials/protocols for early and advanced disease, patients will receive tomorrow’s treatment today. A strong affiliation and collaborative approach with two of the world’s foremost cancer and research institutions, UCLA’s Jonsson Comprehensive Cancer Center and The David Geffen School of Medicine at UCLA, enables us the ability to offer patients unique access to world leaders in cancer research.
